Results 41 to 50 of about 247,599 (243)
An Unusual Case of Stent-in-Stent Thrombosis
A 71-year-old man was admitted for acute coronary syndrome. Six weeks earlier, he had a Promus Premier 3.0 × 12-mm (Boston Scientific, Natick, Massachusetts) drug-eluting stent (DES) implanted in the obtuse marginal (OM) artery for unstable angina. On repeat coronary angiography, haziness ([
Fam, JM +3 more
openaire +2 more sources
An investigation into the influence of stent strut thickness on in-stent restenosis using the finite element method [PDF]
In-stent restenosis represents the major limitation for stenting procedures. In-stent restenosis is the renarrowing o f the artery lumen within a stent predominantly due to excessive growth of neointimal hyperplasia.
Basir, Fariza Fida
core +2 more sources
Background: Conventional statistical methods used in clinical trials lack the ability to predict patient specific risk and very often do not consider the effects of time varying interventions.
Nadira Hamid +11 more
doaj +1 more source
Stent thrombosis: a clinical perspective.
The invention of intracoronary stents greatly increased the safety and applicability of percutaneous coronary interventions. At this time, >1 million coronary stent implantations are performed each year in the United States. But together with the growing use of stents, stent thrombosis, the most feared complication after stent implantation, has emerged
Claessen, Bimmer E. +5 more
openaire +4 more sources
Case Report: INTRAPROCEDURAL STENT THROMBOSIS IN PERCUTANEOUS CORONARY ANGIOPLASTY
Stent thrombosis is a rare complication of PCI but associated with STEMI and sudden cardiac death. Intra procedural stent thrombosis (IPST) was defined new or increasing (compared with baseline) thrombus within or adjacent to a deployed stent occurring ...
Yudi Her Oktaviono
doaj +1 more source
Background While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is frequently undertaken in them.
Keisuke Shoji +4 more
doaj +1 more source
Biodegradable and Biocompatible Functional Polymers for Biomedical Applications
Biodegradable and biocompatible functional polymers integrate electrical, mechanical, and stimuli‐responsive functionalities while enabling programmed degradation under physiological conditions. This review introduces recent advances in conductive, shape‐memory, self‐healing, photocurable, and adhesive polymer systems, emphasizing material design ...
Won Bae Han +5 more
wiley +1 more source
A polymeric graft loaded with radiopaque bismuth nanoparticles is expected to undergo gradual polymer resorption and nanoparticle release. This design enables noninvasive, multimodal monitoring of device integrity, patency, and degradation using computed tomography alongside ultrasound and photoacoustic imaging over 12 weeks.
Allan John R. Barcena +13 more
wiley +1 more source
Bivalirudin started during emergency transport for primary PCI. [PDF]
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Prats, Jayne +54 more
core +1 more source
Very late stent thrombosis is a rare but devastating complication after percutaneous coronary revascularization. Pathological studies have demonstrated that neoatherosclerosis plays a major role in certain patients with very late stent thrombosis ...
Teresa Bastante +6 more
doaj +1 more source

